Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90. https://doi.org/10.1097/CM9.0000000000002108.

Article  PubMed  Google Scholar 

Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412–28. https://doi.org/10.1016/S0140-6736(22)00323-3.

Article  PubMed  Google Scholar 

Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–19.

Article  CAS  PubMed  Google Scholar 

Stålberg K, Bjurberg M, Borgfeldt C, Carlson J, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Hjerpe E, Holmberg E, Kjølhede P, Marcickiewicz J, Rosenberg P, Tholander B, Åvall-Lundqvist E, Högberg T. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Oncol. 2019;58(11):1628–33. Epub 2019 Aug 2. PMID: 31373248.

Article  PubMed  Google Scholar 

Li Y, Cong P, Wang P, Peng C, Liu M, Sun G. Risk factors for pelvic lymph node metastasis in endometrial cancer. Arch Gynecol Obstet. 2019;300(4):1007–1013. doi: 1.1007/s00404-019-05276-9. Epub 2019 Aug 21. PMID: 31435773.

Hui C, Mendoza MG, von Eyben R, Dorigo O, Litkouhi B, Renz M, Karam A, Hammer PM, Howitt BE, Kidd E. Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma? Gynecol Oncol. 2023;177:150–6. Epub 2023 Sep 9. PMID: 37696217.

Article  CAS  PubMed  Google Scholar 

Buechi CA, Siegenthaler F, Sahli L, Papadia A, Saner FAM, Mohr S, Rau TT, Solass W, Imboden S, Mueller MD. Real-World Data assessing the impact of Lymphovascular Space Invasion on the diagnostic performance of Sentinel Lymph Node Mapping in Endometrial Cancer. Cancers (Basel). 2023;16(1):67. https://doi.org/10.3390/cancers16010067. PMID: 38201495; PMCID: PMC10778553.

Article  PubMed  Google Scholar 

Asami Y, Hiranuma K, Takayanagi D, Matsuda M, Shimada Y, Kato MK, Kuno I, Murakami N, Komatsu M, Hamamoto R, Kohno T, Sekizawa A, Matsumoto K, Kato T, Yoshida H, Shiraishi K. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer. Sci Rep. 2022;12(1):19004. https://doi.org/10.1038/s41598-022-23252-3. PMID: 36347927; PMCID: PMC9643353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller HA, Tran A, LyBarger KS, Frieboes HB. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients. Eur J Surg Oncol. 2024;50(1):107309. https://doi.org/10.1016/j.ejso.2023.107309. Epub 2023 Dec 1. PMID: 38056021.

Article  PubMed  Google Scholar 

Shawn LyBarger K, Miller HA, Frieboes HB. CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting. Sci Rep. 2022;12(1):19783. https://doi.org/10.1038/s41598-022-22026-1. PMID: 36396713; PMCID: PMC9671890.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Restaino S, Tortorella L, Dinoi G, Zannoni GF, Baroni A, Capasso I, Distefano E, Sozzi G, Chiantera V, Scambia G, Fanfani F. Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: prognostic and clinical implications. Eur J Cancer. 2021;142:29–37. Epub 2020 Nov 17. PMID: 33217679.

Article  PubMed  Google Scholar 

Tortorella L, Restaino S, Zannoni GF, Vizzielli G, Chiantera V, Cappuccio S, Gioè A, La Fera E, Dinoi G, Angelico G, Scambia G, Fanfani F. Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer. J Gynecol Oncol. 2021;32(2):e11. Epub 2021 Jan 11. PMID: 33470061; PMCID: PMC7930448.

Article  PubMed  PubMed Central  Google Scholar 

Siegenthaler F, Epstein E, Büchi CA, Gmür A, Saner FACM, Rau TT, Carlson JW, Mueller MD, Imboden S. Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer. Int J Gynecol Cancer. 2023;33(11):1702–7. https://doi.org/10.1136/ijgc-2023-004606. PMID: 37666529; PMCID: PMC10646877.

Article  PubMed  PubMed Central  Google Scholar 

Qin ZJ, Wang YS, Chen YL, Zheng A, Han L. Evaluation of prognostic significance of lymphovascular space invasion in early stage endometrial cancer: a systematic review and meta-analysis. Front Oncol. 2024;13:1286221. https://doi.org/10.3389/fonc.2023.1286221. PMID: 38273843; PMCID: PMC10808564.

Article  PubMed  PubMed Central  Google Scholar 

Yarandi F, Shirali E, Akhavan S, Nili F, Ramhormozian S. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer. Eur J Med Res. 2023;28(1):118. https://doi.org/10.1186/s40001-023-01084-9. PMID: 36915143; PMCID: PMC10012545.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayhan A, Şahin H, Sari ME, Yalçin I, Haberal A, Meydanli MM. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer. Int J Gynecol Cancer. 2019;29(3):505–12. https://doi.org/10.1136/ijgc-2018-000069. Epub 2019 Jan 21. PMID: 30665899.

Article  PubMed  Google Scholar 

Dai Y, Dong Y, Cheng Y, Hou H, Wang J, Wang Z, Wang J. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center. J Gynecol Oncol. 2020;31(3):e27. https://doi.org/10.3802/jgo.2020.31.e27. Epub 2019 Nov 28. PMID: 31912681; PMCID: PMC7189077.

Article  PubMed  Google Scholar 

Ureyen I, Karalok A, Turkmen O, Kimyon G, Akdas YR, Akyol A, Tasci T, Turan T. Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI? Arch Gynecol Obstet. 2020;301(3):737–44. https://doi.org/10.1007/s00404-019-05418-z. Epub 2019 Dec 27. PMID: 31883046.

Article  CAS  PubMed  Google Scholar 

Pifer PM, Jaishankar S, Bhargava R, Schad MD, Keller A, Musunuru HB, Cohen M, Sukumvanich P, Courtney-Brooks M, Boisen M, Berger JL, Olawaiye A, Lesnock J, Edwards R, Taylor S, Vargo JA, Beriwal S. Is substantial Lymphovascular Space Invasion Prognostic in patients with pathologically Lymph Node-negative endometrial Cancer? Int J Radiat Oncol Biol Phys 2023 Mar 8:S0360-3016(23)00214-6. https://doi.org/10.1016/j.ijrobp.2023.02.053. Epub ahead of print. PMID: 36893818.

Navarro B, Margioula-Siarkou C, Petousis S, Floquet A, Babin G, Guyon F. Surgical restaging of patients with early–stage endometrial cancer with lymphovascular invasion does not significantly impact their survival outcomes. Oncol Lett. 2023;25(3):122. https://doi.org/10.3892/ol.2023.13708. PMID: 36844624; PMCID: PMC9950339.

Article  PubMed  PubMed Central  Google Scholar 

Chen KS, Berhane H, Gill BS, Olawaiye A, Sukumvanich P, Kelley JL, Boisen MM, Courtney-Brooks M, Comerci JT, Edwards R, Berger J, Beriwal S. Outcomes of stage II endometrial cancer: the UPMC Hillman Cancer Center experience. Gynecol Oncol. 2017;147(2):315–9. Epub 2017 Aug 31. PMID: 28866431.

Article  PubMed  Google Scholar 

Zheng W. Molecular classification of Endometrial Cancer and the 2023 FIGO staging: exploring the challenges and opportunities for pathologists. Cancers (Basel). 2023;15(16):4101. https://doi.org/10.3390/cancers15164101. PMID: 37627129; PMCID: PMC10452831.

Article  CAS  PubMed  Google Scholar 

Dou Y, Song K, Fu Y, Shen Y, Zhang C, Yao S, Xu C, Xia M, Lou G, Liu J, Lin B, Wang J, Zhao W, Zhang J, Cheng W, Guo H, Guo R, Xue F, Wang X, Han L, Zhao X, Li X, Zhang P, Zhao J, Ma J, Li W, Yang X, Wang Z, Liu J, Fang Y, Li K, Chen G, Sun C, Cheng X, Jiang J, Wang B, Luo D, Kong B. Chinese Endometrial Carcinoma Consortium (CECC). Risk factors and prognosis of early recurrence in Stage I-II Endometrial Cancer: a Large-Scale, Multi-center, and Retrospective Study. Front Med (Lausanne). 2022;9:808037. https://doi.org/10.3389/fmed.2022.808037. PMID: 35492356; PMCID: PMC9046937.

Article  PubMed  Google Scholar 

Garzon S, Grassi T, Mariani A, Kollikonda S, Weaver AL, McGree ME, Petersen IA, Weroha SJ, Glaser GE, Langstraat CL, Amarnath SR, AlHilli MM. Not all stage I and II endometrial cancers are created equal: recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer. Gynecol Oncol. 2022;167(3):444–51. https://doi.org/10.1016/j.ygyno.2022.10.004. Epub 2022 Oct 14. PMID: 36244826.

Article  PubMed  Google Scholar 

Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S105-43. https://doi.org/10.1016/S0020-7292(06)60031-3. PMID: 17161155.

Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG, Gynecologic Oncology Group. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–51. https://doi.org/10.1016/j.ygyno.2003.11.048. Erratum in: Gynecol Oncol. 2004;94(1):241-2. PMID: 14984936.

Article  PubMed  Google Scholar 

Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N. Endometrial Cancer staging Subcommittee, FIGO Women’s Cancer Committee. FIGO staging of endometrial cancer: 2023. J Gynecol Oncol. 2023;34(5):e85. https://doi.org/10.3802/jgo.2023.34.e85. Epub 2023 Aug 8. PMID: 37593813; PMCID: PMC10482588.

Article  PubMed  PubMed Central  Google Scholar 

Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N. Endometrial Cancer Staging Subcommittee, FIGO Women’s Cancer Committee. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. 2023;162(2):383–394. https://doi.org/10.1002/ijgo.14923. Epub 2023 Jun 20. Erratum in: Int J Gynaecol Obstet. 2023;: PMID: 37337978.

Bayramoglu D, Seçilmiş Kerimoğlu Ö,